Oral Session 2-9A Multiple Myeloma: Basic (1)

[OS2-9A-2] BCMA is differentially downregulated in myeloma cells by anti-myeloma agents

Yusuke Inoue^1,2, Takeshi Harada³, Asuka Oda¹, Masahiro Oura^1,3, Kimiko Sogabe¹, Kengo Udaka³, Shiro Fujii³, Shingen Nakamura¹, Hirokazu Miki⁴, Kumiko Kagawa³, Masahiro Abe¹ (1.Department of Hematology, Endocrinology and Metabolism, Tokushima University, Japan, 2.Department of Laboratory Medicine, Tokushima University Hospital, Japan, 3.Department of Hematology, Tokushima University Hospital, Japan, 4.Department of Transfusion Medicine and Cell Therapy, Tokushima University, Japan)